Accelerate Diagnostics
AXDX
S$0.04378
Share price
0.00%
Change (1 day)
-97.45%
Change (1 year)
Categories
Revenue for Accelerate Diagnostics (AXDX)
Revenue in 2024 (TTM): S$15.63 Million
According to Accelerate Diagnostics's latest financial reports the company's current revenue (TTM 
) is S$15.06 Million. a decrease over the revenue in the year 2023 that were of S$15.92 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Accelerate Diagnostics from 1996 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | S$15.9 M | -0.16% |
| 2023 | S$15.92 M | -6.83% |
| 2022 | S$17.09 M | 7.33% |
| 2021 | S$15.92 M | 7.84% |
| 2020 | S$14.76 M | 17.83% |
| 2019 | S$12.53 M | 61.81% |
| 2018 | S$7.74 M | 38.68% |
| 2017 | S$5.58 M | 1468.77% |
| 2016 | S$0.35 M | 71.22% |
| 2015 | S$0.2 M | 28.99% |
| 2014 | S$0.16 M | 162.68% |
| 2013 | S$0.06 M | |
| 2011 | S$0.71 M | -81.27% |
| 2010 | S$3.81 M | 305.19% |
| 2009 | S$0.94 M | -30.12% |
| 2008 | S$1.34 M | 288.5% |
| 2007 | S$0.34 M | 6.52% |
| 2006 | S$0.32 M | -48.74% |
| 2005 | S$0.63 M | -15877.97% |
| 2004 | -S$0.01 Million | -100.46% |
| 2003 | S$0.87 M | -34.03% |
| 2002 | S$1.33 M | 38.28% |
| 2001 | S$0.96 M | -53.23% |
| 2000 | S$2.06 M | -49.83% |
| 1999 | S$4.1 M | -46.25% |
| 1998 | S$7.63 M | -22.35% |
| 1997 | S$9.83 M | 205.61% |
| 1996 | S$3.21 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | S$55.23 B | 366,612.26% | 🇺🇸 USA |
 PerkinElmer
PKI | S$4.32 B | 28,601.07% | 🇺🇸 USA |
 Becton Dickinson BDX | S$26.86 B | 178,280.92% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | S$3.27 B | 21,622.35% | 🇺🇸 USA |
 NanoString Technologies NSTG | S$0.20 B | 1,288.90% | 🇺🇸 USA |
 Bruker BRKR | S$4.43 B | 29,358.88% | 🇺🇸 USA |